OVID
Ovid Therapeutics Inc.
NASDAQ · Healthcare · Biotechnology · US
$2.74
+14.17%Forward multiples
Based on analyst estimates
- P/E forward
- —
- P/E 2026E
- —
- P/E 2027E
- —
- P/E 2028E
- —
- P/S forward
- 1375.17x
Trailing multiples
Trailing twelve months
- P/E TTM
- —
- PEG TTM
- —
- Price / book
- 2.55x
- Price / sales
- 338.04x
- Price / cash flow
- -9.77x
Enterprise value
- Enterprise value
- $430.6M
- EV / sales
- 272.02x
- EV / EBITDA
- -12.08x
- EV / EBIT
- -7.38x
- Market cap
- $535.1M
Trailing, forward and enterprise-value multiples for the requested listing · Data as of Jun 1, 2026